121 related articles for article (PubMed ID: 7195207)
1. Comparative cardiovascular effects of three benzimidazole derivatives, AR-L 57 BS, AR-L 100 BS, and AR-L 115 BS.
Diederen W; Kadatz R
Arzneimittelforschung; 1981; 31(1a):141-6. PubMed ID: 7195207
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the positive-inotropic activity of the benzimidazole derivative AR-L 115 BS in isolated guinea pig atria.
Dahmen M; Greeff K
Arzneimittelforschung; 1981; 31(1a):161-5. PubMed ID: 7195212
[TBL] [Abstract][Full Text] [Related]
3. Effects of AR-L 115 BS, a new cardiotonic compound, on cardiac contractility, heart rate and blood pressure in anaesthetized and conscious animals.
Diederen W; Kadatz R
Arzneimittelforschung; 1981; 31(1a):146-50. PubMed ID: 7195208
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of the positive inotropic agents pimobendan and sulmazole in vivo.
von Meel JC
Arzneimittelforschung; 1985; 35(1A):284-8. PubMed ID: 4039168
[TBL] [Abstract][Full Text] [Related]
5. [Animal studies on the tolerability of AR-L 115 BS (author's transl)].
Schneider P; Bauer M; Eckenfels A; Lehmann H; Lützen L; Ueberberg H
Arzneimittelforschung; 1981; 31(1a):226-32. PubMed ID: 7195227
[TBL] [Abstract][Full Text] [Related]
6. Interaction of AR-L 115 BS with isoprenaline on hemodynamic parameters in the isolated guinea pig heart.
Schrader J
Arzneimittelforschung; 1981; 31(1a):183-5. PubMed ID: 7195216
[TBL] [Abstract][Full Text] [Related]
7. The acute effect of a new positive inotropic agent (AR-L 115 BS) on cardiac hemodynamics and contractility in patients with severe chronic congestive heart failure.
Hauf GF; Bubenheimer P; Roskamm H
Arzneimittelforschung; 1981; 31(1a):253-6. PubMed ID: 7195235
[TBL] [Abstract][Full Text] [Related]
8. [The effect of AR-L 115 BS on contractility dynamics of the isolated, metabolically supported dog heart (author's transl)].
Hockerts T; Höcht B; Broll R; Trenkel K; Sieber J; Kilian A; Brendle B
Arzneimittelforschung; 1981; 31(1a):157-61. PubMed ID: 7195211
[TBL] [Abstract][Full Text] [Related]
9. A new non-glycoside, non-adrenergic cardiotonic agent AR-L 115 BS. Hemodynamic proof of its efficacy after both i.v. and oral administration.
Thormann J; Kramer W; Schlepper M
Arzneimittelforschung; 1981; 31(1a):273-8. PubMed ID: 7195241
[TBL] [Abstract][Full Text] [Related]
10. Effects of AR-L 115 BS on hemodynamics, myocardial oxygen consumption and cardiac pumping efficiency.
Hellige G; Baller D; Ensink FB; Zipfel J; Wolpers HG; Bretschneider HJ
Arzneimittelforschung; 1981; 31(1a):155-6. PubMed ID: 7195210
[TBL] [Abstract][Full Text] [Related]
11. Experiments with AR-L 115 BS on skinned cardiac fibers.
Trube G; Trautwein W
Arzneimittelforschung; 1981; 31(1a):185-8. PubMed ID: 7195217
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of sulmazole (AR-L 115 BS) on contractile force and cyclic AMP levels in canine ventricular muscle: comparison with MDL 17,043.
Endoh M; Yanagisawa T; Morita T; Taira N
J Pharmacol Exp Ther; 1985 Jul; 234(1):267-73. PubMed ID: 2989507
[TBL] [Abstract][Full Text] [Related]
13. Activating effects of AR-L 115 BS on the Ca2+ sensitive force, stiffness and unloaded shortening velocity (Vmax) in isolated contractile structures from mammalian heart muscle.
Herzig JW; Feile K; Rüegg JC
Arzneimittelforschung; 1981; 31(1a):188-91. PubMed ID: 7195218
[TBL] [Abstract][Full Text] [Related]
14. The hemodynamic effect of AR-L 115 BS, a new positive-inotropic agent, in patients with left ventricular failure.
Wollschläger H; Drexler H; Löllgen H; Just H
Arzneimittelforschung; 1981; 31(1a):248-50. PubMed ID: 7195233
[TBL] [Abstract][Full Text] [Related]
15. Influence on hemodynamic parameters after parenteral administration of AR-L 115 BS in patients with acute myocardial infarction.
Nebel W; Sabin G; Surawitzki G
Arzneimittelforschung; 1981; 31(1a):251-3. PubMed ID: 7195234
[TBL] [Abstract][Full Text] [Related]
16. Onset and magnitude of cardiovascular response to dobutamine and AR-L 115 BS, a new positive inotropic agent with additional vasodilating activity, in normal subjects.
Benedikter L; Mey T
Arzneimittelforschung; 1981; 31(1a):239-42. PubMed ID: 7195230
[TBL] [Abstract][Full Text] [Related]
17. Study of the acute effect of AR-L 115 BS, a new positive-inotropic agent in patients with exercise-induced heart failure.
Drexler H; Wollschläger H; Löllgen H; Just H
Arzneimittelforschung; 1981; 31(1a):259-62. PubMed ID: 7195237
[TBL] [Abstract][Full Text] [Related]
18. [AR-L 115 BS, comparison of human metabolite pattern and biotransformation with other species].
Roth W; Prox A; Reuter A; Schmid J; Zimmer A; Zipp H
Arzneimittelforschung; 1981; 31(1a):232-5. PubMed ID: 7195228
[TBL] [Abstract][Full Text] [Related]
19. Action of AR-L 115 BS on myocardial oxygen consumption, cardiac performance and vascular resistance and capacitance.
Dämmgen J; Kadatz R; Diederen W
Arzneimittelforschung; 1981; 31(1a):151-4. PubMed ID: 7195209
[TBL] [Abstract][Full Text] [Related]
20. [Human pharmacokinetics of AR-L 115 BS (author's transl)].
Roth W; Zimmer A; Busch U
Arzneimittelforschung; 1981; 31(1a):236-9. PubMed ID: 7195229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
